Biohaven, a privately-held biopharmaceutical company, has appointed Jim Engelhart as its CFO.
Here are five things to know about Mr. Engelhart.
1. He has an extensive professional background that spans research and development finance, commercial strategy, accounting and internal controls, corporate financial reporting, financial planning and analysis and commercial operations, according to a news release.
2. He joins Biohaven from Alexion Pharmaceuticals, where he was an executive director providing financial leadership in the North America and Latin America regions, including financial and commercial support for the launch of two orphan drug indications.
3. Mr. Engelhart has more than 17 years of financial leadership experience in global pharmaceutical business units at Bristol-Myers Squibb, Schering-Plough and Alexion.
4. Mr. Engelhart's business experience also includes two overseas management assignments as well as financial and operational leadership in business integrations, restructurings and acquisitions.
5. Mr. Engelhart earned a bachelor's degree in accountancy from Villanova (Pa.) University and is a certified public accountant.
More articles on executive moves:
17 latest hospital, health system executive moves
George Washington University Hospital names new CEO: 4 things to know
3 Columbus Regional Health executives resign to take promotions elsewhere